<DOC>
	<DOCNO>NCT00912405</DOCNO>
	<brief_summary>This study allow continued access Sinexus Intranasal Splint marketing application prepare . This study generate additional performance , reimbursement safety data steroid-eluting Sinexus Intranasal Splint use follow Functional Endoscopic Sinus Surgery ( FESS ) patient chronic sinusitis ( CS ) .</brief_summary>
	<brief_title>Clinical Evaluation Steroid-Eluting Sinexus Intranasal Splint When Used Following Functional Endoscopic Sinus Surgery ( FESS ) Patients With Chronic Sinusitis</brief_title>
	<detailed_description />
	<mesh_term>Sinusitis</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<criteria>Patient 18 year age old Patient diagnosis chronic sinusitis Patient clinical indication consent FESS Patient CT scan confirms CS diagnosis within 6 month procedure CT sacn confirm presence disease ethmoid sinus ( e ) Planned FESS include unilateral bilateral total ethmoidectomy Immune deficiency ( IGG subclass deficiency IGA deficiency ) Oralsteroid dependent COPD , asthma condition Clinical evidence acute bacterial sinusitis History diagnosis glaucoma ocular hypertension Clinical evidence suspicion invasive fungal sinusitis Evidence disease condition expect compromise survival ability complete followup Known history allergy intolerance corticosteroid History insulin dependent diabetes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Patients diagnose Chronic Sinusitis undergo functional endoscopic surgery ( FESS )</keyword>
</DOC>